Detalles de la búsqueda
1.
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
Biol Chem
; 403(5-6): 545-556, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717050
2.
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.
Cancer
; 127(18): 3413-3421, 2021 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181755
3.
Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia.
Br J Haematol
; 193(3): 592-601, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838047
4.
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy.
Haematologica
; 106(7): 1857-1866, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499243
5.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Eur J Haematol
; 107(5): 529-542, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34270825
6.
An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts.
Blood
; 130(13): 1543-1552, 2017 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28698205
7.
Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials.
Eur J Haematol
; 103(3): 255-267, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231828
8.
High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Br J Haematol
; 182(6): 807-815, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984825
9.
Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.
Blood
; 128(26): 3169-3176, 2016 12 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27811019
10.
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA).
Haematologica
; 103(9): 1422-1432, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30049825
11.
From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives.
Haematologica
; 103(2): 197-211, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29217780
12.
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation.
Haematologica
; 103(2): 237-245, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29101205
13.
European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.
Haematologica
; 103(11): 1772-1784, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171031
14.
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT).
Br J Haematol
; 178(4): 521-533, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28589551
15.
Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial.
Br J Haematol
; 179(4): 586-597, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28961309
16.
Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Haematologica
; 102(2): 381-390, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658435
17.
Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation.
Haematologica
; 102(4): 796-803, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28057735
18.
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients.
Haematologica
; 102(11): 1947-1955, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28883078
19.
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.
Transfus Med Hemother
; 44(5): 292-300, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29070974
20.
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
Haematologica
; 106(9): 2507-2510, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33882638